Status:
COMPLETED
19F Thoracic Radiotherapy for Lung Cancer
Lead Sponsor:
Hal C Charles
Conditions:
Lung Cancer
Eligibility:
All Genders
18-99 years
Phase:
EARLY_PHASE1
Brief Summary
The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy...
Detailed Description
Primary Objective: Determine feasibility by evaluating if: PO1: Patients diagnosed with lung cancer are able to successfully complete pre- and post-radiotherapy 19F MR imaging scans as scheduled. S...
Eligibility Criteria
Inclusion
- Subject has histologic or cytologic confirmation of lung cancer (NSCLC or Small cell) and has been recommended thoracic radiotherapy as part of standard of care management.
- Ability to undergo MR imaging, tolerate breath hold procedures and follow direction during the imaging process
- Karnofsky performance status ≥60, with expected survival of ≥6 months
- At least 18 years of age
- Patient is not pregnant
- Patient can be reliably reached for post-MRI follow up AE check.
- Patient able to sign a study specific informed consent form.
Exclusion
- Any condition including, metallic implants or cardiac pacemakers that makes the candidate ineligible for MR imaging. (MRI research screening form will be completed prior to each MRI scan).
- Malignant pleural effusion or pericardial effusion
Key Trial Info
Start Date :
February 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2019
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03315065
Start Date
February 16 2018
End Date
June 25 2019
Last Update
July 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center - Cancer Center
Durham, North Carolina, United States, 27705